Long-Term Propranolol Use in Severely Burned Pediatric Patients
David N. Herndon(Joseph M. Still Research Foundation), Celeste C. Finnerty(The University of Texas Medical Branch at Galveston), Ronald P. Mlcak(Shriners Hospitals for Children - Galveston), Oscar E. Suman(The University of Texas Medical Branch at Galveston), Kristofer Jennings, Jong O. Lee(University of North Carolina at Chapel Hill), Felicia Williams(The University of Texas Medical Branch at Galveston), Sachin Hegde(Shriners Hospitals for Children - Galveston), Jaipreet S. Suri(Indiana University School of Medicine), Noe A. Rodriguez(Shriners Hospitals for Children - Galveston), Walter J. Meyer(National Institutes of Health), Marc G. Jeschke(Thrombosis and Atherosclerosis Research Institute), Robert E. Barrow(Child Mind Institute), Eva C. Diaz(Shriners Hospitals for Children - Galveston)
Cited by 155
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
The leading causes of death after burn injury in a single pediatric burn center
|Critical Care|2009|376
Non-cystic Fibrosis Bronchiectasis
|Unknown|2012|254
Intensive Insulin Therapy in Severely Burned Pediatric Patients: A Prospective Randomized Trial
|American Journal of Respiratory and Critical Care Medicine|2010|210
Longitudinal assessment of Integra in primary burn management: A randomized pediatric clinical trial*
|Critical Care Medicine|2007|185